Smart Insulin Development
Todd discusses the development of a smart insulin that can adjust glucose levels, potentially eliminating the risk of low blood sugars. He also touches on the FDA approval process for a faster acting insulin product, highlighting the complexities of naming a new medication for safety reasons.In this clip
From this podcast

Juicebox Podcast: Type 1 Diabetes
#8 4 Novo Nordisk VP and CMO Todd Hobbs
Related Questions